Search filters

List of works by Dana E. Rathkopf

A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer

scientific article

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol

scientific article

A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors.

scientific article published on 12 May 2010

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer.

scientific article published on 9 March 2010

A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors.

scientific article

A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer ⬇️

scientific article published on May 2, 2012

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3

scientific article published on 16 January 2015

Abiraterone in metastatic prostate cancer without previous chemotherapy

scientific article published on 10 January 2013

Androgen receptor antagonists in castration-resistant prostate cancer.

scientific article

Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.

scientific article

Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer

scientific article published on 04 July 2015

Enzalutamide in metastatic prostate cancer before chemotherapy

scientific article published in June 2014

Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.

scientific article

Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer

scientific article

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.

scientific article published on 29 October 2013

Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate

scientific article published on 15 January 2015

Integrative Clinical Genomics of Advanced Prostate Cancer.

scientific article

Integrative clinical genomics of advanced prostate cancer

scientific article

Organoid cultures derived from patients with advanced prostate cancer

scientific article

Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer

scientific article

Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors.

scientific article published in October 2007

Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer.

scientific article

Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer

scientific article

Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors

scientific article

Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer

scientific article

Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.

scientific article

Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.

scientific article

Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America

scientific article published on 14 February 2015

Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians.

scientific article published on 22 November 2014

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium [...]

scientific article

Paulina is supported by:

About Paulina

Help